Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist* - Wikidata - awgldk - TriplyDB

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

http://www.wikidata.org/entity/Q28315344

about

Tracking the emerging human pathogen Pseudallescheria boydii by using highly specific monoclonal antibodies Infections caused by Scedosporium spp.Osteoarticular Infections Caused by Non-Aspergillus Filamentous Fungi in Adult and Pediatric Patients: A Systematic Review Monoclonal antibodies against peptidorhamnomannans of Scedosporium apiospermum enhance the pathogenicity of the fungus Characterization of Scedosporium apiospermum glucosylceramides and their involvement in fungal development and macrophage functions A Multifaceted Study of Scedosporium boydii Cell Wall Changes during Germination and Identification of GPI-Anchored Proteins Secretion of Proteases by an Opportunistic Fungal Pathogen Scedosporium aurantiacum Combination antifungal therapy for invasive mould diseases in haematologic patients. An update on clinical data.Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environments and their distribution in clinical samples.Heterothallism in Scedosporium apiospermum and description of its teleomorph Pseudallescheria apiosperma sp. nov.Recurrent Scedosporium apiospermum mycetoma successfully treated by surgical excision and terbinafine treatment: a case report and review of the literature Infection with Scedosporium apiospermum and S. prolificans, Australia.Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi The changing microbial epidemiology in cystic fibrosis.Rapid identification of Pseudallescheria and Scedosporium strains by using rolling circle amplification.Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis.Purification and characterization of a mycelial catalase from Scedosporium boydii, a useful tool for specific antibody detection in patients with cystic fibrosis.Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review.Synthesis and antifungal activity of functionalized 2,3-spirostane isomers Fatal mycotic aneurysms due to Scedosporium and Pseudallescheria infection Susceptibility and diversity in the therapy-refractory genus scedosporium Phenotypic profiling of Scedosporium aurantiacum, an opportunistic pathogen colonizing human lungs.Graphium basitruncatum fungemia in a patient with acute leukemia.Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry.Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006.Scedosporium apiospermum infection after near-drowning.Development and validation of a quantitative PCR assay for diagnosis of scedosporiosis.Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum.Two cases of severe pneumonia after the 2011 Great East Japan Earthquake Central nervous system infections by members of the Pseudallescheria boydii species complex in healthy and immunocompromised hosts: epidemiology, clinical characteristics and outcome.Biochemical characterization of potential virulence markers in the human fungal pathogen Pseudallescheria boydii.The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro.Glycoconjugates and polysaccharides from the Scedosporium/Pseudallescheria boydii complex: structural characterisation, involvement in cell differentiation, cell recognition and virulence.Current status of antifungal resistance and its impact on clinical practice.Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014.Scedosporium apiospermum Otitis Complicated by a Temporomandibular Arthritis: A Case Report and Mini-Review.Toward the Standardization of Mycological Examination of Sputum Samples in Cystic Fibrosis: Results from a French Multicenter Prospective Study.Pseudallescheria fusoidea, a new cause of osteomyelitis Metallopeptidase inhibitors arrest vital biological processes in the fungal pathogen Scedosporium apiospermum.

P2860

Q24644571-495631E7-B4BE-492E-A3E7-BA0139E2894C Q24657691-94932558-FC84-45BC-A6FF-B24F2CD3FAD0 Q26774766-C9AD7F90-AEC0-4148-9CA6-989327EADF66 Q27306696-C38B9B20-238E-49D7-9475-337B7D978763 Q28539197-E7715030-BFF4-472D-A397-D15676D70B45 Q28547775-FD75D075-E73E-4F10-B65E-041F45649BBC Q28817844-500144B7-9CF5-4BE3-AB3C-92CBE1ACB4C8 Q30873926-52F757AE-3468-43C9-84CE-7715B0511A10 Q33393265-974E977E-7DF2-45EA-8CD6-F2C563E9E0BC Q33439771-B2D1E2B5-7FFC-4DC7-92EA-E1A4360E89CE Q33564554-BF370CC6-F6ED-4966-8957-20CCBF17DD15 Q33686144-0779F531-D98C-4F1E-87B3-CD957AB1B5E8 Q33792765-360FBAE8-AC6E-4500-ADDA-51B21B5B1487 Q33825634-50766843-FFC2-4299-9B19-512080A58E69 Q34068354-42DF6F6D-BADB-4C14-9AA4-3611CE369A5C Q34130445-FFA11F35-5D7C-4C75-8ED9-712C9FEC97FB Q34785000-419529AD-A177-4512-BED4-C02A52873F2C Q34910464-1D6BBBC5-9916-4DB6-8FE2-A7B8EB78E075 Q34953266-8581E010-526B-41DA-84B0-C5921E3FDE98 Q35066568-FD755491-390F-4ED9-A91E-6D5576A591E8 Q35214490-024BD00C-D819-45E4-8906-4527152C1502 Q35220005-F144421A-49A4-4B59-83C8-B438A3012D56 Q35784472-F853F455-430A-4E4E-9964-5E93D885D35B Q35819627-F651E625-D77C-4609-8C26-8CB8AE9ED78A Q36593781-0B42731F-B956-42AA-90FB-57FBCE1B10CA Q36655030-1B73E67C-2350-4080-94B8-280416509B39 Q36917112-371619DF-DD54-41F4-9E15-36F2E9D70437 Q36933405-34A2A8BE-3969-4451-AE62-A08531D3A611 Q37009066-EFC5E5E9-6F3C-4AEC-B03D-1FA4E8A8105C Q37059102-6E764F2B-0D3F-4D12-9FCC-AB3D0E518D9C Q37106636-4FC03B0C-5B89-40FF-8E25-F320801A71F1 Q37398912-112FB5F2-AD0B-415B-A1B5-DC99580EB276 Q37700546-D4D7701A-35B9-4AA9-89E4-E7E6DA9250DA Q37945312-02E6435E-7F22-430F-BD01-1C62979866C5 Q38205859-76747FA1-B747-45C4-A6ED-804FEEC74AAE Q38284463-5130A06E-A5B6-4FC2-8306-6BEF711A3497 Q38536383-F6747C80-403A-46A3-87AF-F3846E12DF03 Q38651242-6984B815-262E-46E7-941C-011A09CCFD1B Q39761725-425C1F1E-A1ED-4EC7-97A1-3F09A5A4AAEE Q39952905-5B5F7664-AEDB-4469-A647-166FBAF79BFA

P2860

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

http://www.wikidata.org/entity/Q28315344

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

@ast

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

@en

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

@nl

type

label

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

@ast

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

@en

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

@nl

prefLabel

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

@ast

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

@en

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

@nl

P1433

Q28315344-D17E644F-0917-4267-9AFF-21076F60554C

P1476

Q28315344-69161285-CC78-4C5A-BE22-881E017CE5EA

P2093

Q28315344-14661D3E-66E8-4DAD-87FE-CAF425850C7B

Q28315344-45226D34-73C2-4120-8B13-0461A46A4140

Q28315344-50BCE052-31FC-46C2-90B9-F86F2E66C563

Q28315344-52E2BFB8-C7B7-40E4-BB4F-FFB4510F2B6F

Q28315344-6D01FE4E-B9BC-4A94-9BA0-2BAA743C8F0C

Q28315344-8DD4474A-E005-4B35-8258-F53469D241CA

P2860

Q28315344-0144C0AB-93DE-4230-9363-A5D8D575CC05

Q28315344-01A2A1C0-2028-4985-A7CD-BF434F598A97

Q28315344-03A0FEA0-158A-4DDD-8DAE-A4C8EEFE6DBC

Q28315344-0A83B962-0479-4C03-AEB1-19DF2C3B439E

Q28315344-0BD16D5A-308A-4D18-9D33-0B40A635207A

Q28315344-0CD50BDF-62D4-484E-B8C9-0EA21B4AC506

Q28315344-0FDE3527-0D17-497E-B803-4B99BFF3C4CD

Q28315344-123FB4B5-2E19-43FF-8F29-80DD25681418

Q28315344-145A7886-013E-43A5-8989-B847B130B784

Q28315344-14D9AC09-6F7F-482B-A5ED-67D594979066

P304

Q28315344-C9B5A283-7D3D-4F24-8918-7D9AF8CAD266

P31

Q28315344-BC000B59-7C24-4945-9EEE-5CC9FD55EF66

P356

Q28315344-8DA21876-21B4-4BBF-B16A-C5CE678831E6

P433

Q28315344-64D1B5FD-75A1-4451-BA8C-546C38526283

P478

Q28315344-D1C97407-98C2-43A1-9275-908BD5C7BE09

P50

Q28315344-12ED5AAB-18B0-4BB6-B0A6-DA9563795181

P577

Q28315344-1EA1547F-CFA7-4167-9FF5-7A530B07CFB8

P5875

Q28315344-C073D5B6-3B71-4264-B4E2-0E9D86E5BBAF

P698

Q28315344-8A64EABC-FF4E-4C28-B04B-D676F65E5E88

P921

Q28315344-5974C398-6C15-4E8B-9708-E3D439E25B40

P356

13693780600752507

P1433

Medical Mycology

P1476

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

@en

P2093

A. Serda Kantarcioglu

http://www.w3.org/2001/XMLSchema#string

G. Sybren De Hoog

http://www.w3.org/2001/XMLSchema#string

Juan Berenguer

http://www.w3.org/2001/XMLSchema#string

Juan Luis Rodriguez-Tudela

http://www.w3.org/2001/XMLSchema#string

Manuel Cuenca Estrella

http://www.w3.org/2001/XMLSchema#string

Regine Horré

http://www.w3.org/2001/XMLSchema#string

P2860

Mixed allergic bronchopulmonary fungal disease due to Pseudallescheria boydii and Aspergillus

Pneumonia associated with near-drowning

Molecular Phylogeny of the Pseudallescheria boydii Species Complex: Proposal of Two New Species

In vitro activities of four novel triazoles against Scedosporium spp

In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi

A peptidorhamnomannan from the mycelium of Pseudallescheria boydii is a potential diagnostic antigen of this emerging human pathogen.

Lymphadenitis caused by Scedosporium apiospermum in an immunocompetent patient.

Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy.

In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp.

Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis.

P304

295-327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13693780600752507

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7011792

http://www.w3.org/2001/XMLSchema#string

P698

16772225

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease